GSA Capital Partners’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

GSA Capital Partners’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,597	Closed	-$227K	–	2240
2025 Q1	$227K	Buy	+12,597	New	+$224K	0.02%	1334
2024 Q4	–	Sell	-11,796	Closed	-$136K	–	2104
2024 Q3	$136K	Sell	11,796 -24,611	-68%	-$282K	0.01%	1460
2024 Q2	$412K	Sell	36,407 -49,391	-58%	-$657K	0.03%	1088
2024 Q1	$1.23M	Buy	85,798 +13,596	+19%	+$193K	0.1%	315
2023 Q4	$990K	Sell	72,202 -20,020	-22%	-$211K	0.08%	400
2023 Q3	$750K	Buy	92,222 +44,410	+93%	+$363K	0.06%	552
2023 Q2	$362K	Buy	+47,812	New	+$365K	0.04%	935

GSA Capital Partners's PTVE Position: Q2 2025 in Review

GSA Capital Partners sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 12,597 shares — an estimated $227K sold.

GSA Capital Partners first reported a position in PTVE in Q2 2023 and held it in 7 quarters. The position peaked at $1.23M in Q1 2024. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

GSA Capital Partners reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
GSA Capital Partners sold 12,597 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $227K.
GSA Capital Partners first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2023 and held it in 7 quarters.
GSA Capital Partners's Pactiv Evergreen Inc. Common stock position peaked at $1.23M in Q1 2024.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.